Skip header and navigation

Refine By

335 records – page 1 of 34.

[4th Congress of the International Perinatal Doppler Society 29-31 August 1991 in Malmö]

https://arctichealth.org/en/permalink/ahliterature59657
Source
Zentralbl Gynakol. 1992;114(4):211-4
Publication Type
Conference/Meeting Material
Date
1992

The 7th European Placenta Group Meeting, Vigsø, Denmark, 13-17 December 1997.

https://arctichealth.org/en/permalink/ahliterature64188
Source
Placenta. 1998 May;19(4):341-4
Publication Type
Conference/Meeting Material
Date
May-1998
Author
C H Graham
Author Affiliation
Department of Anatomy and Cell Biology, Queen's University, Kingston, Ontario, Canada.
Source
Placenta. 1998 May;19(4):341-4
Date
May-1998
Language
English
Publication Type
Conference/Meeting Material
Keywords
Animals
Disease Transmission, Vertical
Drug Delivery Systems
Europe
Female
Humans
Maternal-Fetal Exchange
Pharmacokinetics
Placenta - physiology
Pregnancy
PubMed ID
9735019 View in PubMed
Less detail

25-Hydroxyvitamin D concentrations in maternal and cord blood at delivery and in maternal blood during lactation in Finland.

https://arctichealth.org/en/permalink/ahliterature240391
Source
Hum Nutr Clin Nutr. 1984 Jul;38(4):261-8
Publication Type
Article
Date
Jul-1984
Author
C. Lamberg-Allardt
M. Larjosto
E. Schultz
Source
Hum Nutr Clin Nutr. 1984 Jul;38(4):261-8
Date
Jul-1984
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Alkaline Phosphatase - blood
Calcifediol - blood
Calcium - blood
Cholecalciferol - administration & dosage
Female
Fetal Blood - metabolism
Finland
Food Habits
Humans
Infant, Newborn
Lactation
Maternal-Fetal Exchange
Nutritional Requirements
Pregnancy
Seasons
Vitamin D Deficiency - blood
Abstract
The 25-hydroxyvitamin D concentration (25-OHD) in maternal and cord blood of 192 mothers was determined at delivery from June to the end of November. Ninety-nine mothers had received a daily supplementation of 12.5 micrograms of vitamin D during pregnancy and this group had a significantly higher 25-OHD concentration both in maternal and in cord blood than in the corresponding non-supplemented group. A daily supplement of 2.5 micrograms of vitamin D was given to 63 of the mothers during lactation. Of these mothers 44 were still lactating after 6 months. The dietary vitamin D intake of 31 mothers was calculated. We found a significant correlation between the maternal serum 25-OHD concentration 16-18 weeks after delivery and the total vitamin D intake. The intake (5.5 micrograms/d, including supplementation) was lower than that recommended for lactating mothers which is 10 micrograms/d (Food and Nutrition Board, 1980).
PubMed ID
6088438 View in PubMed
Less detail

131I dose to the human fetal thyroid in the Zagreb district, Yugoslavia, from the Chernobyl accident.

https://arctichealth.org/en/permalink/ahliterature65399
Source
Int J Radiat Biol. 1988 Aug;54(2):167-77
Publication Type
Article
Date
Aug-1988
Author
M. Basic
B. Kasal
I. Simonovic
S. Jukic
Author Affiliation
Department of Nuclear Medicine, Clinical Hospital Centre-Rebro and Medical Faculty, Zagreb, Yugoslavia.
Source
Int J Radiat Biol. 1988 Aug;54(2):167-77
Date
Aug-1988
Language
English
Publication Type
Article
Keywords
Accidents
Female
Humans
Iodine Radioisotopes - metabolism
Maternal-Fetal Exchange
Nuclear Reactors
Pregnancy
Radiation Dosage
Radioactive fallout
Thyroid Gland - metabolism
Ukraine
Yugoslavia
Abstract
The 131I activity was measured in 30 human fetal thyroids in Zagreb district after the Chernobyl accident. A model of radioiodine metabolism in the mother and human fetus which takes into account the age dependence of the uptake and retention of radioiodine in the fetal thyroid was developed. Having assessed that the total intake by the average mother was about 1330 Bq, a good correlation between calculated and measured fetal thyroid activities was found (r = 0.77, P less than 0.001). The fetal thyroid dose reached the maximum of 0.43 micro Gy/Bq intake at about the fifth month of gestation. It was concluded that the risk of having a child with a harmful trait due to 131I absorbed by the mother was negligible.
PubMed ID
2900274 View in PubMed
Less detail

ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta.

https://arctichealth.org/en/permalink/ahliterature92634
Source
Toxicol Appl Pharmacol. 2008 Oct 15;232(2):210-7
Publication Type
Article
Date
Oct-15-2008
Author
Myllynen Päivi
Kummu Maria
Kangas Tiina
Ilves Mika
Immonen Elina
Rysä Jaana
Pirilä Rauna
Lastumäki Anni
Vähäkangas Kirsi H
Author Affiliation
Department of Pharmacology and Toxicology, University of Oulu, PO Box 5000, 90014, Oulu, Finland. paivi.myllynen@oulu.fi
Source
Toxicol Appl Pharmacol. 2008 Oct 15;232(2):210-7
Date
Oct-15-2008
Language
English
Publication Type
Article
Keywords
ATP-Binding Cassette Transporters - physiology
Carcinogens - metabolism - toxicity
Cell Line, Tumor
Drug Resistance, Multiple - physiology
Female
Food - toxicity
Humans
Imidazoles - metabolism - toxicity
Maternal-Fetal Exchange - physiology
Neoplasm Proteins - physiology
Perfusion - methods
Placenta - drug effects - metabolism
Pregnancy
Abstract
We have studied the role of ATP binding cassette (ABC) transporters in fetal exposure to carcinogens using 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) a known substrate for ABC transporters as a model compound. In perfusion of human term placenta, transfer of (14)C-PhIP (2 microM) through the placenta resulted in fetal-to-maternal concentration ratio (FM ratio) of 0.72+/-0.09 at 6 h. The specific ABCG2 inhibitor KO143 increased the transfer of (14)C-PhIP from maternal to fetal circulation (FM ratio 0.90+/-0.08 at 6 h, p
PubMed ID
18680760 View in PubMed
Less detail

[A case of death of a newborn infant delivered by a mother sensitized to antibiotics]

https://arctichealth.org/en/permalink/ahliterature61061
Source
Pediatr Akus Ginekol. 1972 May-Jun;3:27-8
Publication Type
Article

[A cohort of newborn infants, drugs and pregnancy]

https://arctichealth.org/en/permalink/ahliterature58981
Source
Tidsskr Nor Laegeforen. 1998 Apr 30;118(11):1761-2
Publication Type
Article
Date
Apr-30-1998

[A drink can harm the baby in the womb].

https://arctichealth.org/en/permalink/ahliterature129549
Source
Ugeskr Laeger. 2011 Nov 14;173(46):2939
Publication Type
Article
Date
Nov-14-2011

Alcohol and drug screening of newborns: would women consent?

https://arctichealth.org/en/permalink/ahliterature150543
Source
J Obstet Gynaecol Can. 2009 Apr;31(4):331-9
Publication Type
Article
Date
Apr-2009
Author
Matthew Hicks
Suzanne C Tough
Shahirose Premji
Karen Benzies
Andrew W Lyon
Ian Mitchell
Reg Sauve
Author Affiliation
Department of Community Health Sciences, University of Calgary and Calgary Health Region, Calgary AB, Canada.
Source
J Obstet Gynaecol Can. 2009 Apr;31(4):331-9
Date
Apr-2009
Language
English
Publication Type
Article
Keywords
Adult
Canada
Cross-Sectional Studies
Female
Humans
Infant, Newborn
Maternal-Fetal Exchange
Neonatal Screening
Parental Consent
Pregnancy
Questionnaires
Substance Abuse Detection
Abstract
To examine the conditions under which mothers would consent to alcohol and drug screening of their infants, and to identify predictors of screening consent.
A cross-sectional survey was administered in person by trained research assistants on the postpartum units of three hospitals in a large Canadian urban centre over four months. The survey was administered to 1509 mothers (78.4% of those eligible) who were fluent in English and had given birth within the preceding 48 hours.
Mothers indicated that they would consent to screening of their newborn (1369/1460, 93.8%), and thought all mothers should consent if infants at risk would be more likely to receive effective treatment (1440/1476, 97.6%). Respondents believed that they would consent to screening if they were provided the following information: what would happen if the infant sample was positive for prenatal exposure (1431/1476, 97%); who would have access to the information (1377/1476, 93.4%); how effective medical care would be for the child (1435/1476, 97.4%); and the likelihood that a baby with a positive screen would have a problem (1444/1476, 98.1%). Self-reported alcohol use did not decrease willingness to consent. In a multivariate model, belief that universal screening would not make women feel discriminated against was a significant predictor of consent (adjusted OR 5.9; 95% CI 3.3-10.6).
Mothers would support a universal newborn alcohol and drug screening program if there was evidence that screening could lead to effective treatment for the mother and baby, and if appropriate resources were available.
PubMed ID
19497152 View in PubMed
Less detail

335 records – page 1 of 34.